ResearcherPurdue University West LafayetteActive in the last 2 years
Yi Yang
Matched on ORCID iD 0000-0002-0219-2611; OpenAlex author ID A5101639938. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 7
- Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. First author DOI 10.1002/1878-0261.13552↗
- Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. First author DOI 10.1111/jth.15115↗
- A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/smll.201905500↗
- An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations. Co-author DOI 10.1039/d0lc00707b↗
- Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. Co-author DOI 10.1158/0008-5472.can-18-3206↗
- Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemc… Co-author DOI 10.1002/1878-0261.12314↗
- Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer. Co-author DOI 10.1080/15384101.2016.1148838↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen F Konieczny · 6 shared papers, 2016–2021 · strength 0.63
- Paper A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma. DOI 10.1002/smll.201905500↗
- Paper An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations. DOI 10.1039/d0lc00707b↗
- Paper Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. DOI 10.1111/jth.15115↗
- Matthew J. Flick · 3 shared papers, 2019–2024 · strength 0.39
- Paper Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. DOI 10.1002/1878-0261.13552↗
- Paper Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. DOI 10.1111/jth.15115↗
- Paper Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. DOI 10.1158/0008-5472.can-18-3206↗
- Patrick G. Schweickert · 4 shared papers, 2016–2021 · strength 0.35
- Paper Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. DOI 10.1111/jth.15115↗
- Paper Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. DOI 10.1158/0008-5472.can-18-3206↗
- Paper Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic … DOI 10.1002/1878-0261.12314↗
- Bumsoo Han · 2 shared papers, 2020 · strength 0.28
- Melissa L. Fishel · 1 shared paper, 2024 · strength 0.18
- Alisa S. Wolberg · 1 shared paper, 2024 · strength 0.18
- Nayela N. Chowdhury · 1 shared paper, 2024 · strength 0.18
- Fenil Shah · 1 shared paper, 2024 · strength 0.18
- Michael J. Bradney · 1 shared paper, 2020 · strength 0.15
- Hye‐ran Moon · 1 shared paper, 2020 · strength 0.13
- Nigel Mackman · 1 shared paper, 2021 · strength 0.12
- Emily White · 1 shared paper, 2021 · strength 0.12
- Yunlong Liu · 1 shared paper, 2018 · strength 0.08
- Brad L. Jakubison · 1 shared paper, 2018 · strength 0.08
- Pamela Itkin‐Ansari · 1 shared paper, 2018 · strength 0.08
- Jie Li · 1 shared paper, 2016 · strength 0.06
- Nihal Ahmad · 1 shared paper, 2016 · strength 0.06
- Xiaoqi Liu · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.